Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients’ Health State Utility

[1] Panchal SJ(2007)Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden Int J Clin Pract 61 1181-1187

[2] Muller-Schwefe P(2014)Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review Clinicoecon Outcomes Res 6 269-281

[3] Wurzelmann JI(2006)Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment Eur J Pain 10 287-333

[4] Coyne KS(2011)Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact Curr Med Res Opin 27 449-462

[5] LoCasale RJ(2009)The role of opioids in managing chronic non-cancer pain Ann Acad Med Singapore 38 960-966

[6] Datto CJ(2015)Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids J Pain Res 8 459-475

[7] Sexton CC(2011)The prevalence, correlates and treatment of pain in the European Union Curr Med Res Opin 27 463-480

[8] Yeomans K(2010)The prevalence of chronic pain in United States adults: results of an Internet-based survey J Pain 11 1230-1239

[9] Tack J(2011)A population-based survey of chronic pain and its treatment with prescription drugs Pain 152 1249-1255

[10] Breivik H(2007)Chronic pain in Canada: have we improved our management of chronic noncancer pain? Pain Res Manag 12 39-47

[1] Panchal SJ(2007)Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden Int J Clin Pract 61 1181-1187

[2] Muller-Schwefe P(2014)Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review Clinicoecon Outcomes Res 6 269-281

[3] Wurzelmann JI(2006)Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment Eur J Pain 10 287-333

[4] Coyne KS(2011)Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact Curr Med Res Opin 27 449-462

[5] LoCasale RJ(2009)The role of opioids in managing chronic non-cancer pain Ann Acad Med Singapore 38 960-966

[6] Datto CJ(2015)Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids J Pain Res 8 459-475

[7] Sexton CC(2011)The prevalence, correlates and treatment of pain in the European Union Curr Med Res Opin 27 463-480

[8] Yeomans K(2010)The prevalence of chronic pain in United States adults: results of an Internet-based survey J Pain 11 1230-1239

[9] Tack J(2011)A population-based survey of chronic pain and its treatment with prescription drugs Pain 152 1249-1255

[10] Breivik H(2007)Chronic pain in Canada: have we improved our management of chronic noncancer pain? Pain Res Manag 12 39-47